Bevacizumab has been sold as Avastin by originator Roche for many years and used by the NHS for various forms of cancer, with ...

Get the latest U.S. stock market and healthcare sector updates, key company news, and top healthcare winners and losers.

The EU document dated 11 November was circulated internally after the EU announced its supply deal with Pfizer and its German partner BioNTech on 11 November ...

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added a brain tumor warning to the drug's label.

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

The action follows mounting scientific evidence linking the injectable contraceptive medication to an increased risk for meningioma.

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

Fosun is joining the fray through its subsidiary Yao Pharma, which has granted Pfizer an exclusive worldwide license to ...

In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & Immunology Annual Scientific ...

Pfizer has won a $10 billion deal to acquire the fast-rising obesity drug developer Metsera, ending a fierce bidding war with Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer ...

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy. By Francesca Regalado The obesity drug developer ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...